Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
Background Antipsychotic-induced weight gain constitutes a major unresolved clinical
problem which may ultimately be associated with reducing life expectancy by 25 years …
problem which may ultimately be associated with reducing life expectancy by 25 years …